These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 26888504)
1. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma]. Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma. Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401 [TBL] [Abstract][Full Text] [Related]
3. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma. Huang W; Cheng X; Ji J; Zhang J; Li Q Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716 [TBL] [Abstract][Full Text] [Related]
4. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma. Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433 [TBL] [Abstract][Full Text] [Related]
5. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes. Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423 [TBL] [Abstract][Full Text] [Related]
6. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary. Kandalaft PL; Gown AM; Isacson C Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337 [TBL] [Abstract][Full Text] [Related]
7. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells. Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor. Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020 [TBL] [Abstract][Full Text] [Related]
9. HNF-1β in ovarian carcinomas with serous and clear cell change. DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869 [TBL] [Abstract][Full Text] [Related]
10. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas. Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours. Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297 [TBL] [Abstract][Full Text] [Related]
12. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis. Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029 [TBL] [Abstract][Full Text] [Related]
13. Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Yamashita Y; Nagasaka T; Naiki-Ito A; Sato S; Suzuki S; Toyokuni S; Ito M; Takahashi S Mod Pathol; 2015 Jan; 28(1):111-7. PubMed ID: 24721826 [TBL] [Abstract][Full Text] [Related]
14. Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction. Ji JX; Cochrane DR; Tessier-Cloutier B; Leung S; Cheng AS; Chow C; Gilks B; Huntsman DG; Hoang LN Int J Gynecol Pathol; 2020 Jul; 39(4):344-353. PubMed ID: 31094885 [TBL] [Abstract][Full Text] [Related]
15. Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract. Pors J; Segura S; Cheng A; Ji JX; Tessier-Cloutier B; Cochrane D; Fix DJ; Park K; Gilks B; Hoang L Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):593-601. PubMed ID: 31361605 [TBL] [Abstract][Full Text] [Related]
16. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546 [TBL] [Abstract][Full Text] [Related]
17. Napsin-A, a Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas. Alshenawy HA; Radi DA Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):605-610. PubMed ID: 28362708 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions. Davidson B Cancer Cytopathol; 2014 Feb; 122(2):153-8. PubMed ID: 24115587 [TBL] [Abstract][Full Text] [Related]
19. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma. Kato N; Toukairin M; Asanuma I; Motoyama T Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940 [TBL] [Abstract][Full Text] [Related]
20. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]